Pinegap automates the parts of an equity analyst’s week that are structured enough to automate. Company Primer builds the initial ramp onto an unfamiliar name, Proxy Review reads board structure and management compensation, Risk Tracker surfaces forensic accounting signals, and earnings previews and recaps handle the reporting cycle.
Ramping onto a new company is the right problem to attack. It is days of reading filings and transcripts before an analyst has any view at all, it is almost entirely mechanical, and it is the single biggest constraint on how many names one person can cover. The thesis dashboard then tracks whether the argument still holds as new information lands, which is the discipline most analysts intend to keep and quietly do not.
Access is a two-week trial requested through a form asking for a fund name, which tells you the buyer. No pricing is published, forensic accounting signals are leads rather than findings, and anything an automated summary produces still has to be checked against the filing before it reaches an investment decision.
